drugset / Trial / NCT00683111

Prevention of Gastrointestinal Bleeding in Patients With Severe Ischemic Heart Disease

NCT00683111

Phase 4 Completed 500 enrolled Ruttonjee Hospital
RandomizedParallel-groupQuadruple-blindPrevention

Summary

Aspirin and clopidogrel +/- heparin or thrombolytic co-therapy is well established and effective treatment for unstable cardiac patients. However, the major complication was gastrointestinal bleeding (GIB) due to peptic ulcer. In the prevention of GIB, anti-ulcer drug either H2-receptor antagonist (H2RA) and proton pump inhibitor (PPI) were commonly prescribed. There has been no prospective controlled study to compare the efficacy of these two classes of anti-ulcer drugs.

Timeline

Start
2008-07
Primary completion
2011-12
Completion
2011-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Esomeprazole Small molecule 20 mg Oral
Comparator Famotidine Other / unclassified 40 mg Oral